相似文献
1
Protein tyrosine phosphatases as wardens of STAT signaling.
JAKSTAT. 2014 Jan 1;3(1):e28087. doi: 10.4161/jkst.28087. Epub 2014 Feb 20.
2
Regulation of signal transducer and activator of transcription signaling by the tyrosine phosphatase PTP-BL.
Immunity. 2007 Feb;26(2):163-76. doi: 10.1016/j.immuni.2007.01.010.
3
Protein tyrosine phosphatases in the JAK/STAT pathway.
Front Biosci. 2008 May 1;13:4925-32. doi: 10.2741/3051.
4
TC-PTP and PTP1B: Regulating JAK-STAT signaling, controlling lymphoid malignancies.
Cytokine. 2016 Jun;82:52-7. doi: 10.1016/j.cyto.2015.12.025. Epub 2016 Jan 23.
5
Activation of signal transducers and activators of transcription 1 and 3 by leukemia inhibitory factor, oncostatin-M, and interferon-gamma in adipocytes.
J Biol Chem. 1998 Nov 20;273(47):31408-16. doi: 10.1074/jbc.273.47.31408.
6
The role of STATs in transcriptional control and their impact on cellular function.
Oncogene. 2000 May 15;19(21):2468-73. doi: 10.1038/sj.onc.1203476.
7
A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus.
Mol Endocrinol. 2002 Jan;16(1):58-69. doi: 10.1210/mend.16.1.0761.
8
Protein Tyrosine Phosphatases as Potential Regulators of STAT3 Signaling.
Int J Mol Sci. 2018 Sep 11;19(9):2708. doi: 10.3390/ijms19092708.
9
Protein tyrosine phosphatases as novel targets in breast cancer therapy.
Biochim Biophys Acta. 2013 Dec;1836(2):211-26. doi: 10.1016/j.bbcan.2013.06.001. Epub 2013 Jun 10.
10
Protein tyrosine phosphatases, TC-PTP, SHP1, and SHP2, cooperate in rapid dephosphorylation of Stat3 in keratinocytes following UVB irradiation.
PLoS One. 2010 Apr 22;5(4):e10290. doi: 10.1371/journal.pone.0010290.
引用本文的文献
1
Recent advances and future perspectives in small molecule JAK2 inhibitors.
Future Med Chem. 2025 May;17(10):1175-1191. doi: 10.1080/17568919.2025.2507564. Epub 2025 May 20.
2
JAK-STAT pathway, type I/II cytokines, and new potential therapeutic strategy for autoimmune bullous diseases: update on pemphigus vulgaris and bullous pemphigoid.
Front Immunol. 2025 Apr 8;16:1563286. doi: 10.3389/fimmu.2025.1563286. eCollection 2025.
3
Network pharmacology, bioinformatics analysis, and experimental validation to reveal the target and pharmacological mechanism of DHDK in treating breast cancer.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 14. doi: 10.1007/s00210-025-04138-3.
4
Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies.
Adv Sci (Weinh). 2025 Jan;12(3):e2410416. doi: 10.1002/advs.202410416. Epub 2024 Dec 12.
5
Integrative Multi-PTM Proteomics Reveals Dynamic Global, Redox, Phosphorylation, and Acetylation Regulation in Cytokine-Treated Pancreatic Beta Cells.
Mol Cell Proteomics. 2024 Dec;23(12):100881. doi: 10.1016/j.mcpro.2024.100881. Epub 2024 Nov 15.
6
Age-associated myeloid malignancies - the role of STAT3 and STAT5 in myelodysplastic syndrome and acute myeloid leukemia.
FEBS Lett. 2024 Nov;598(22):2809-2828. doi: 10.1002/1873-3468.14985. Epub 2024 Jul 24.
7
Upregulation of TCPTP in Macrophages Is Involved in IL-35 Mediated Attenuation of Experimental Colitis.
Mediators Inflamm. 2024 Jun 13;2024:3282679. doi: 10.1155/2024/3282679. eCollection 2024.
8
Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice.
PLoS Pathog. 2024 Apr 15;20(4):e1012132. doi: 10.1371/journal.ppat.1012132. eCollection 2024 Apr.
9
Targeting STAT3 and NF-κB Signaling Pathways in Cancer Prevention and Treatment: The Role of Chalcones.
Cancers (Basel). 2024 Mar 8;16(6):1092. doi: 10.3390/cancers16061092.
10
Rheumatoid arthritis-recent advances in pathogenesis and the anti-inflammatory effect of plant-derived COX inhibitors.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Aug;397(8):5363-5385. doi: 10.1007/s00210-024-02982-3. Epub 2024 Feb 15.
本文引用的文献
1
PTP-central: a comprehensive resource of protein tyrosine phosphatases in eukaryotic genomes.
Methods. 2014 Jan 15;65(2):156-64. doi: 10.1016/j.ymeth.2013.07.031. Epub 2013 Jul 31.
2
Shp1 regulates T cell homeostasis by limiting IL-4 signals.
J Exp Med. 2013 Jul 1;210(7):1419-31. doi: 10.1084/jem.20122239.
3
Regulation of STAT signaling by acetylation.
Cell Signal. 2013 Sep;25(9):1924-31. doi: 10.1016/j.cellsig.2013.05.007. Epub 2013 May 22.
4
Protein tyrosine phosphatase variants in human hereditary disorders and disease susceptibilities.
Biochim Biophys Acta. 2013 Oct;1832(10):1673-96. doi: 10.1016/j.bbadis.2013.05.022. Epub 2013 May 23.
5
Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia.
Blood. 2013 May 30;121(22):4541-50. doi: 10.1182/blood-2012-12-474577. Epub 2013 Apr 17.
6
Wedelolactone, a naturally occurring coumestan, enhances interferon-γ signaling through inhibiting STAT1 protein dephosphorylation.
J Biol Chem. 2013 May 17;288(20):14417-14427. doi: 10.1074/jbc.M112.442970. Epub 2013 Apr 11.
7
Suppression of cytokine signaling: the SOCS perspective.
Cytokine Growth Factor Rev. 2013 Jun;24(3):241-8. doi: 10.1016/j.cytogfr.2013.03.005. Epub 2013 Mar 30.
8
The nucleus- and endoplasmic reticulum-targeted forms of protein tyrosine phosphatase 61F regulate Drosophila growth, life span, and fecundity.
Mol Cell Biol. 2013 Apr;33(7):1345-56. doi: 10.1128/MCB.01411-12. Epub 2013 Jan 22.
9
Central regulation of metabolism by protein tyrosine phosphatases.
Front Neurosci. 2013 Jan 7;6:192. doi: 10.3389/fnins.2012.00192. eCollection 2012.
10
Signal transducer and activator of transcription 3 (STAT3) regulates collagen-induced platelet aggregation independently of its transcription factor activity.
Circulation. 2013 Jan 29;127(4):476-485. doi: 10.1161/CIRCULATIONAHA.112.132126. Epub 2012 Dec 24.
Zotero 插件